Ann: Extension of Voluntary Suspension, page-31

I guess it all depends on how much leverage the debt holders have. If the non disclosure of the Galderma contract gives them a legal way to demand early repayment and thus bankrupt the company then I would imagine the dilution will be severe. If the company doesn't have that extreme time pressure to do a deal then it might be a bit more reasonable. Unfortunately though I think the $1 days are well behind us... And although it is only a side issue I am still intrigued by the continued reference that the company is considering its response to public reports. Dunno how they could sue anyone for enough to make any difference to the bottom line and they will always have their own non-disclosure failings to deal with.